<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01395771</url>
  </required_header>
  <id_info>
    <org_study_id>BSCDC2011HIV/AIDS</org_study_id>
    <secondary_id>BSWSJ2011HIV/AIDS</secondary_id>
    <nct_id>NCT01395771</nct_id>
  </id_info>
  <brief_title>Effects of a Phone Call Intervention to Promote HAART Adherence</brief_title>
  <acronym>EPCIPHA</acronym>
  <official_title>Effects of a Phone Call Intervention to Promote HAART Adherence in Baoshan, China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baoshan Prefecture Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prince of Songkla University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baoshan Prefecture Center for Disease Control and Prevention</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The adherence rate (95%) to HAART in the intervention group which receives a phone call will
      be higher than that(75%)of control group which does not receive a phone call.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to above eligibility criteria, getting two eligible group patients, one which are
      patients newly required HAART (new cases) and the other who have received HAART for 1-3
      years(old cases). All eligible patients in each group will be randomly assigned to
      intervention and control group by block randomization. Among of them, one group with a phone
      call intervention, the other without. New cases will be followed up for 3 months and study
      outcomes will be assessed at the baseline and the 2nd week, the 1st month and 2nd month, and
      the 3rd month. For the old cases, study outcomes will be assessed only at the baseline survey
      and at the 3rd month.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline HAART adherence within 3 months</measure>
    <time_frame>HAART adherence for new cases will be assessed at the 2nd week, the 1st month and 2nd month, and the 3rd month follow-up. For old cases HAART adherence will be assessed only at the baseline survey and the 3rd month follow-up</time_frame>
    <description>Adherence will be measured at different time points within 3 months follow-up (study period)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline quality of life within 3 months</measure>
    <time_frame>Quality of life for new cases will be assessed at the baseline survey and the 2nd week, the 1st month and 2nd month, and the 3rd month. For old cases quality of life will be assessed only at the baseline survey and the end of the 3rd month</time_frame>
    <description>Quality of life will be measured at different time points within 3 months study periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4 cell counts</measure>
    <time_frame>CD4 will be measured at the baseline survey and the 3rd month follow-up</time_frame>
    <description>CD4 cell counts will be measured only at baseline survey and after 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with side effects</measure>
    <time_frame>Number of side effects for new cases will be assessed at the 2nd week, the 1st month and 2nd month, and the 3rd month follow-up. For old cases the number of side effects will be assessed only at the baseline survey and the 3rd month follow-up</time_frame>
    <description>The number of side effects will be measured at different time points within 3 months follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of opportunistic infection within 3 months</measure>
    <time_frame>Number of opportunistic infection for new cases will be assessed at the 2nd week, the 1st month and 2nd month, and the 3rd month follow-up. For old cases number of that will be assessed only at the baseline and the 3rd month follow-up</time_frame>
    <description>Number of opportunistic infection will be measured at different time points within 3 months follow-up period(study period)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Mortality will be assessed the 3rd month follow-up</time_frame>
    <description>Measurement of the number of change of mortality</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Medication Adherence</condition>
  <arm_group>
    <arm_group_label>Phone call</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>New cases and old cases will be randomly categorized into two groups,respectively,one is phone call intervention group, the other is no phone call intervention group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Phone call intervention, no phone call intervention</intervention_name>
    <description>Biweekly phone call intervention +routine service will be assigned to intervention group of new cases and old cases. Only routine service will be assigned to the control group of abovementioned two kind of cases.</description>
    <arm_group_label>Phone call</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Chinese patients with HIV/AIDS aged â‰¥ 18 years and for the newly required HAART
             patients, mainly based on their CD4 &lt; 350 cells/mm3. But irrespective of CD4 cells for
             old patients who are under treatment for 1-3 years.

        Exclusion criteria:

          -  Patients who have the inability to communicate at the beginning of study and who
             haven't got opportunistic infection(this item is only for new cases), who are
             non-Baoshan registered residence, who are foreigners, prisoners and pregnants, who
             have no mobile phone.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weibing Zheng, Bachelor</last_name>
    <role>Study Director</role>
    <affiliation>Baoshan CDC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Longling county hospital</name>
      <address>
        <city>Baoshan</city>
        <state>Yunnan</state>
        <zip>67000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunyan Zhang, Bachelor</last_name>
      <phone>86-0875-6122353</phone>
    </contact>
    <investigator>
      <last_name>Dongsheng Huang, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Longyang district hospital</name>
      <address>
        <city>Baoshan</city>
        <state>Yunnan</state>
        <zip>678000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junmei Duan, Bachelor</last_name>
      <phone>86-0875-2130187</phone>
      <email>892991901@qq.com</email>
    </contact>
    <investigator>
      <last_name>Dongsheng Huang, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tengchong county hospital</name>
      <address>
        <city>Baoshan</city>
        <state>Yunnan</state>
        <zip>678000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Jiang, Bachelor</last_name>
      <phone>86-0875-5137151</phone>
      <email>jt4766@sina.com</email>
    </contact>
    <investigator>
      <last_name>Dongsheng huang, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The first hospital of Baoshan Prefecture</name>
      <address>
        <city>Baoshan</city>
        <state>Yunnan</state>
        <zip>67800</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yikun Hu, Bachelor</last_name>
      <phone>86-0875-2120370</phone>
    </contact>
    <investigator>
      <last_name>Dongsheng Huang, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2011</study_first_submitted>
  <study_first_submitted_qc>July 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2011</study_first_posted>
  <last_update_submitted>July 15, 2011</last_update_submitted>
  <last_update_submitted_qc>July 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>Director of Weibin Zheng</name_title>
    <organization>Baoshan Prefecture Center for Disease Control and Prevention</organization>
  </responsible_party>
  <keyword>Effect</keyword>
  <keyword>Phone call</keyword>
  <keyword>Intervention</keyword>
  <keyword>Promote</keyword>
  <keyword>HAART adherence</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

